Fiona Rutherford

Stay informed with Fiona Rutherford’s coverage and analysis for Fortune.

Page 2 of 2

North Tustin, CA – January 07: A COVID face mask dangles from the rear-view mirror of a car in North Tustin on January 7, 2022. Many people these days hang their mask in their car so that it’s ready to use when they go out in public. Some experts say that the virus is here to stay and that face masks will just be a part of life going forward.

Cloth masks aren’t as effective as N95 masks in warding off COVID, CDC says

By Fiona Rutherford and Bloomberg

SHANGHAI, CHINA – NOVEMBER 07: A visitor takes photos in front of a billboard which introduces an experimental COVID-19 treatment pill called molnupiravir at Merck & Co., Inc. (MSD) booth during the 4th China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) on November 7, 2021 in Shanghai, China. (Photo by Tang Yanjun/China News Service via Getty Images)

Merck says its breakthrough COVID-19 pill doesn’t work nearly as well as previously reported

By Fiona Rutherford and Bloomberg

Former FDA commissioner Robert Califf

Biden nominates one-time FDA commissioner Robert Califf to run the agency again

By Fiona Rutherford, Jeannie Baumann, and others

Pfizer headquarters

FDA panel recommends COVID-19 boosters only for those 65 and older or at high risk

By Robert Langreth, Fiona Rutherford, and others

A nurse reaches for a vial of Pfizer-BioNTech Covid-19 vaccine at a pop up vaccine clinic in the Arleta neighborhood of Los Angeles, California, August 23, 2021. – The US Food and Drug Administration on August 23, fully approved the Pfizer-BioNTech Covid shot, triggering a new wave of vaccine mandates as the Delta variant batters the country.<br />
Around 52 percent of the American population is fully vaccinated, but health authorities have hit a wall of vaccine hesitant people, impeding the national campaign. (Photo by Robyn Beck / AFP) (Photo by ROBYN BECK/AFP via Getty Images)

The FDA is rapidly reviewing COVID vaccines for children under 12

By Fiona Rutherford and Bloomberg

A pedestrian wearing a protective face mask walks past the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia, U.S, on Saturday, March 14, 2020. As the novel coronavirus has spread in the U.S., the CDC is under increasing heat to defend a shaky rollout of crucial testing kits. Photographer: Elijah Nouvelage/Bloomberg

CDC recruits outsiders to lead a new center on disease forecasting

By Drew Armstrong, Fiona Rutherford, and others

MELBOURNE, FLORIDA, UNITED STATES – 2021/05/17: A nurse gives Malikai McPherson, 16, a shot of the vaccine at a vaccination clinic at Health First Medical Centre.<br />
On May 12, 2021, the CDC approved the use of the Pfizer BioNTech vaccine in 12 through 15-year-old adolescents. Vaccinating this age group is seen as a keyway for middle and high schools to reopen fully by this fall. (Photo by Paul Hennessy/SOPA Images/LightRocket via Getty Images)

CDC: Adolescents who have COVID-19 risk hospitalization

By Fiona Rutherford and Bloomberg

23 February 2021, Saxony-Anhalt, Naumburg: A woman undergoes a Corona quick test in a test tent on the market. From 23 to 28 February 2021, all residents of the Burgenland district can be tested here free of charge. The rapid test will be evaluated on site, and in the event of a positive result, a laboratory test will immediately follow, which will also be examined for virus mutations. Photo: Hendrik Schmidt/dpa-Zentralbild/dpa (Photo by Hendrik Schmidt/picture alliance via Getty Images)

COVID is triggering mental and neurological disorders in some survivors, researchers warn

By Fiona Rutherford and Bloomberg